ArticleFrontiers in surgery2025
Clinical comparison between direct anterior approach and posterior lateral approach in total hip arthroplasty and risk factors for lateral femoral cutaneous nerve injury.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Associated factors of nerve injury post-total hip arthroplasty: a meta-analysis.BMC musculoskeletal disorders · 2026Pooled it
- Pooled it
- Article
- A modified direct anterior approach for primary total hip arthroplasty: surgical technique.Journal of orthopaedic surgery and research · 2025Article
- Supine Positioning in Primary Total Hip Replacement is Associated with a Shorter Hospital Stay Than Lateral Positioning: A Retrospective Propensity-Score Matched Cohort Study.Therapeutics and clinical risk management · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to compare the clinical outcomes of total hip arthroplasty (THA) using the lateral decubitus direct anterior approach (DAA) vs. the traditional posterior lateral approach (PLA), and to explore the risk factors and predictive models for lateral femoral cutaneous nerve (LFCN) injury following DAA-THA. Methods: Two hundred patients undergoing primary unilateral THA were randomly assigned to the DAA group and the PLA group, with 100 cases in each group. Clinical data, surgical parameters, postoperative pain scores, and other relevant data were recorded, and the differences between the two groups in terms of treatment outcomes and postoperative recovery were analyzed. Results: Compared to the PLA group, patients in the DAA group had shorter incisions, reduced blood loss and drainage, shorter hospital stays, decreased postoperative inflammatory markers, and lower pain scores. However, the incidence of postoperative LFCN injury was higher in the DAA (DAA:24patients, 24%, PLA:2patients, 2%) group, although most cases resolved within one year. Univariate analysis showed that diabetes, preoperative serum CK levels, serum IL-6, and TNF-α levels at postoperative day 3 were associated with early LFCN injury, while diabetes, BMI, and postoperative inflammation were significantly associated with persistent LFCN injury. Binary logistic regression analysis identified serum IL-6 and TNF-α levels at postoperative day 3 as independent risk factors for persistent LFCN injury. The established predictive model demonstrated good discrimination. Conclusion: Despite slightly longer surgical duration, DAA demonstrated significant advantages in reducing early pain, blood loss, and hospital stay. However, postoperative LFCN injury warrants attention, especially in patients with diabetes and postoperative inflammatory reactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.